학술논문
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B
Document Type
Article
Author
Clark, A.S.; DeMichele, A.M.; O’Dwyer, P.J.; Hong, F.; Gray, R.J.; Wang, V.; Finn, R.S.; Mitchell, E.P.; Zwiebel, J.; Arnaldez, F.I.; McShane, L.M.; Rubinstein, L.V.; Patton, D.; Williams, P.M.; Hamilton, S.R.; Copur, M.S.; Kasbari, S.S.; Thind, R.; Conley, B.A.; Harris, L.N.; Arteaga, C.L.; Chen, A.P.; Flaherty, K.T.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, April 2023, 29(8):1477-1483)
Subject
Language
English
ISSN
15573265
10780432
10780432